AnaptysBio, Inc. (ANAB)
56.28
-1.01
(-1.76%)
USD |
NASDAQ |
Aug 28, 16:00
56.18
-0.10
(-0.17%)
After-Hours: 20:00
AnaptysBio 1 Year Total Returns (Daily) : 319.4% for Aug. 28, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 28, 2026 | 319.4% |
| August 27, 2026 | 321.3% |
| August 26, 2026 | 335.9% |
| August 25, 2026 | 335.7% |
| August 24, 2026 | 333.6% |
| August 21, 2026 | 325.5% |
| August 20, 2026 | 322.1% |
| August 19, 2026 | 349.2% |
| August 18, 2026 | 342.0% |
| August 17, 2026 | 344.6% |
| August 14, 2026 | 339.2% |
| August 13, 2026 | 305.6% |
| August 12, 2026 | 325.1% |
| August 11, 2026 | 334.1% |
| August 10, 2026 | 295.7% |
| August 07, 2026 | 316.9% |
| August 06, 2026 | 264.5% |
| August 05, 2026 | 248.2% |
| August 04, 2026 | 241.3% |
| August 03, 2026 | 226.1% |
| July 31, 2026 | 226.1% |
| July 30, 2026 | 230.6% |
| July 29, 2026 | 198.3% |
| July 28, 2026 | 194.0% |
| July 27, 2026 | 198.5% |
| Date | Value |
|---|---|
| July 24, 2026 | 201.0% |
| July 23, 2026 | 205.1% |
| July 22, 2026 | 201.1% |
| July 21, 2026 | 208.2% |
| July 20, 2026 | 191.1% |
| July 17, 2026 | 226.1% |
| July 16, 2026 | 202.4% |
| July 15, 2026 | 214.5% |
| July 14, 2026 | 248.0% |
| July 13, 2026 | 299.7% |
| July 10, 2026 | 281.8% |
| July 09, 2026 | 288.1% |
| July 08, 2026 | 304.3% |
| July 07, 2026 | 330.7% |
| July 06, 2026 | 293.6% |
| July 02, 2026 | 298.4% |
| July 01, 2026 | 333.4% |
| June 30, 2026 | 356.1% |
| June 29, 2026 | 340.5% |
| June 26, 2026 | 305.2% |
| June 25, 2026 | 285.3% |
| June 24, 2026 | 276.2% |
| June 23, 2026 | 290.7% |
| June 22, 2026 | 288.4% |
| June 18, 2026 | 268.9% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| 4D Molecular Therapeutics, Inc. | 137.4% |
| Design Therapeutics, Inc. | 167.9% |
| Inhibrx Biosciences, Inc. | 342.6% |
| Agenus, Inc. | 80.24% |
| Amgen, Inc. | 55.58% |